Research Article

A Meta-Analysis of Resveratrol Protects against Myocardial Ischemia/Reperfusion Injury: Evidence from Small Animal Studies and Insight into Molecular Mechanisms

Table 2

Characteristics of the ex vivo studies included in the meta-analysis.

AuthorYearStateSpeciesWeight/yearAnestheticAnimal numbersI/R durationVehicleResveratrol treatment
ControlResveratrolDosageApproachTime

Yang et al. [14]2016ChinaRats, SD, M10 weeksChloral hydrate101030 min/1 hK-H solution10 μmol/LPerfusion15 min before I/R
Liao et al. [15]2014ChinaMice, KM, MNASodium pentobarbital6615 min/30 minEthanol2.0 mg/kg.dGavage6 weeks before I/R
Adam et al. [16]2012AfricaRats, LE, M9 weeksSodium pentobarbital6630 min/1 hK-H solution10 mmol/LPerfusion25 min before I/R
Mukhopadhyay et al. [33]2010USARats, SD, M250-300 gSodium pentobarbital6630 min/2 hNA5 mg/kg/dGavage21 days before I/R
Lekli et al. [34]2009USARats, SD, M250-300 gSodium pentobarbital3330 min/2 hNA2.5 mg/kg/dGavage15 days before I/R
Das et al. [35]2006USARats, SD, M250-300 gSodium pentobarbital6630 min/2 hK-H solution10 μmol/LPerfusion20 min before I/R
Ray et al. [36]1999USARats, SD, M275–300 gSodium pentobarbital3330 min/2 hK-H solution10 μmol/LPerfusion15 min before I/R

SD: Sprague-Dawley rats; KM: Kun-Ming; M: male; LE: Long-Evans; K-H solution: Krebs-Henseleit solution; DMSO: dimethyl sulfoxide.